MiRxes Launches Study for Pulmonary Hypertension Biomarkers in Asian Populations
The Singapore-based biotech company will evaluate its miRNA biomarker assay for early detection of pulmonary hypertension as part of the SPHERE study.
The researchers are studying use of pharmacy testing to monitor hypertension and cholesterol as well as for detecting and managing various infectious diseases.
Owlstone Medical, Actelion Pharmaceuticals Partner to Develop Pulmonary Hypertension Breath Test
The firms anticipate discovering and validating a biomarker signature, or signatures, for earlier detection of pulmonary hypertension and its subtypes.
Though the test is already commercially available, the firm met with the FDA last year to discuss plans for a randomized controlled trial to support regulatory approval.
FDA Clears Healthy.io's Smartphone-Enabled Urinalysis Kit
The Dip.io technology uses a smartphone's camera to capture high-quality images of a patient's urinalysis results and immediately send it off for clinical diagnosis.